7 December 2023 - The Biden administration proposed a rule Thursday that could let the Government seize patents for medicines developed with taxpayer money that are not affordable to the public, then license them to another party—the latest in a years-long campaign to stem high prescription drug prices.

The administration cited the government’s “march-in” authority under the Bayh-Dole Act, which allows the government to license an invention made using federal funds to another party if the patent holder doesn’t make the invention accessible to the public.

Read Forbes article